Evidence map›Paper›PMID 37551608›Full record

ArticleCNS oncology2023

Cerebral manifestation and diagnostic dilemma of Rosai-Dorfman disease.

Szintia Almási, Tamás Pancsa, László Tiszlavicz, Anita Sejben

Open access · goldAbstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in CNS oncology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed, 1 pooled it
1.1field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 1 synthesis or guideline pooled it, 6 citations in OpenAlex.

  1. Pooled it
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Szintia AlmásiDepartment of Pathology, Albert Szent-Györgyi Medical Centre, University of Szeged, Szeged, 6725, Hungary.ORCID 0000-0002-7714-2256
Tamás PancsaDepartment of Pathology, Albert Szent-Györgyi Medical Centre, University of Szeged, Szeged, 6725, Hungary.
László TiszlaviczDepartment of Pathology, Albert Szent-Györgyi Medical Centre, University of Szeged, Szeged, 6725, Hungary.ORCID 0000-0003-1134-6587
Anita SejbenDepartment of Pathology, Albert Szent-Györgyi Medical Centre, University of Szeged, Szeged, 6725, Hungary.ORCID 0000-0002-9434-2989
University of Szeged · HU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Rosai-Dorfman disease (RDD) is a rare, S100-positive histiocytic proliferation, that can cause both nodal and extranodal illness. We present a case of a 53-year-old male patient. Magnetic resonance imaging described a plaque-like meningeal lesion, and the preoperative diagnosis was meningioma. Histologically, dense infiltration of lymphocytes, plasma cells, and histiocytes was seen, furthermore, the presence of emperipolesis in the sample was pronounced. In the histiocytes nuclear and cytoplasmic positivity with S100 protein, and nuclear positivity with Cyclin D1 was observed. The case was concluded as RDD. Morphological appearance of intracranial RDD with imaging procedures can present a differential diagnostic challenge. The correct diagnosis is based on the presence of histiocytes with emperipolesis, and properly defined immunohistochemical characteristics.

Indexed as

Histiocytosis, SinusMeningeal NeoplasmsMeningiomaDiagnosis, DifferentialEmperipolesisHistiocytesHumansMaleMiddle AgedS100 ProteinsS100 ProteinshistiocytosisIgG4Rosai-Dorfman diseaseS100

Identifiers

PMID37551608
PMCPMC10701702
OpenAlexW4385660108

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.